Argenx CEO Tim Van Hauwermeiren is stepping down in May and will be succeeded by Karen Massey, the Belgian drugmaker's COO.

Neuralink, a leader in the fledgling field of brain implants, is hurting the industry's efforts to develop useful medical ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter: Alumis: Top-line ...

ATLATL, one of China’s leading biotech incubators, is seeking to bridge East-West innovation and tap into China's rapidly ...

When Americans make decisions — like whether to pack an umbrella or prepare for a hurricane — they rely on clear, timely, and ...

A new year always brings new challenges, and there will be many challenges facing the pharmaceutical industry and policymakers in 2026 as Americans continue to clamor for affordable medicines that ...